Estuardo Aguilar Cordova is > 10% Shareholder of Candel Therapeutics, Inc.. Currently has a direct ownership of 873,512 shares of CADL, which is worth approximately $4 Million. The most recent transaction as insider was on Nov 08, 2024, when has been sold 7,500 shares (CADL) at a price of $4.92 per share, resulting in proceeds of $36,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 874K
20.37% 3M change
20.37% 12M change
Total Value Held $4 Million

Estuardo Aguilar-Cordova Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 08 2024
SELL
Sale (or disposition) back to the issuer
$36,900 $4.92 p/Share
7,500 Reduced 0.85%
873,512 CADL
Nov 07 2024
SELL
Sale (or disposition) back to the issuer
$38,925 $5.19 p/Share
7,500 Reduced 0.84%
881,012 CADL
Nov 06 2024
SELL
Sale (or disposition) back to the issuer
$39,975 $5.33 p/Share
7,500 Reduced 0.84%
888,512 CADL
Nov 01 2024
SELL
Sale (or disposition) back to the issuer
$39,525 $5.27 p/Share
7,500 Reduced 0.83%
896,012 CADL
Oct 31 2024
SELL
Sale (or disposition) back to the issuer
$39,750 $5.3 p/Share
7,500 Reduced 0.82%
903,512 CADL
Oct 30 2024
SELL
Sale (or disposition) back to the issuer
$32,280 $5.38 p/Share
6,000 Reduced 0.65%
911,012 CADL
Oct 28 2024
SELL
Sale (or disposition) back to the issuer
$65,347 $5.58 p/Share
11,711 Reduced 1.3%
888,532 CADL
Oct 25 2024
SELL
Sale (or disposition) back to the issuer
$9,262 $5.8 p/Share
1,597 Reduced 0.18%
900,243 CADL
Oct 24 2024
SELL
Sale (or disposition) back to the issuer
$99,206 $5.63 p/Share
17,621 Reduced 1.92%
901,840 CADL
Oct 15 2024
SELL
Open market or private sale
$62,784 $6.03 p/Share
10,412 Reduced 1.12%
919,461 CADL
Oct 14 2024
SELL
Open market or private sale
$90,300 $6.02 p/Share
15,000 Reduced 1.59%
929,873 CADL
Oct 11 2024
SELL
Open market or private sale
$90,750 $6.05 p/Share
15,000 Reduced 1.56%
944,873 CADL
Oct 03 2024
SELL
Open market or private sale
$12,330 $6.85 p/Share
1,800 Reduced 0.19%
959,873 CADL
Oct 02 2024
SELL
Open market or private sale
$186,756 $6.92 p/Share
26,988 Reduced 2.73%
961,673 CADL
Oct 01 2024
BUY
Open market or private sale
$43,560 $7.01 p/Share
6,214 Added 0.62%
988,661 CADL
May 06 2022
SELL
Payment of exercise price or tax liability
$197,370 $3.65 p/Share
54,074 Reduced 4.7%
1,097,032 Common Stock
May 06 2022
BUY
Exercise of conversion of derivative security
$197,367 $1.46 p/Share
135,183 Added 10.51%
1,151,106 Common Stock
Jul 29 2021
BUY
Conversion of derivative security
-
162,137 Added 13.76%
1,015,923 Common Stock
EA

Estuardo Aguilar Cordova

> 10% Shareholder
Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Track Activities on CADL